Johnson & Johnson Goodwill and Intangible Assets 1986-2025 | JNJ

Johnson & Johnson goodwill and intangible assets from 1986 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
  • Johnson & Johnson goodwill and intangible assets for the quarter ending September 30, 2025 were $97.952B, a 16.64% increase year-over-year.
  • Johnson & Johnson goodwill and intangible assets for 2024 were $81.818B, a 15.67% increase from 2023.
  • Johnson & Johnson goodwill and intangible assets for 2023 were $70.733B, a 5.1% decline from 2022.
  • Johnson & Johnson goodwill and intangible assets for 2022 were $74.536B, a 8.7% decline from 2021.
Johnson & Johnson Annual Goodwill and Intangible Assets
(Millions of US $)
2024 $81,818
2023 $70,733
2022 $74,536
2021 $81,638
2020 $89,795
2019 $81,282
2018 $78,064
2017 $85,134
2016 $49,681
2015 $47,393
2014 $49,054
2013 $50,745
2012 $51,176
2011 $34,276
2010 $32,010
2009 $31,185
2008 $27,695
2007 $28,763
2006 $28,688
2005 $12,175
2004 $11,842
2003 $11,539
2002 $9,246
2001 $9,077
2000 $7,535
1999 $7,571
1998 $7,209
1997 $3,261
1996 $3,107
1995 $2,950
1994 $2,403
1993 $925
1992 $716
1991 $738
1990 $706
1989 $704
1988 $609
1987 $622
1986 $393
1985 $0
Johnson & Johnson Quarterly Goodwill and Intangible Assets
(Millions of US $)
2025-06-30 $97,952
2025-03-31 $81,223
2024-12-31 $81,818
2024-09-30 $84,289
2024-06-30 $83,975
2024-03-31 $70,902
2023-12-31 $70,733
2023-09-30 $71,145
2023-06-30 $91,686
2023-03-31 $93,023
2022-12-31 $74,536
2022-09-30 $73,719
2022-06-30 $76,574
2022-03-31 $79,355
2021-12-31 $81,638
2021-09-30 $83,345
2021-06-30 $86,063
2021-03-31 $86,798
2020-12-31 $89,795
2020-09-30 $81,313
2020-06-30 $81,303
2020-03-31 $80,809
2019-12-31 $81,282
2019-09-30 $81,137
2019-06-30 $82,993
2019-03-31 $78,348
2018-12-31 $78,064
2018-09-30 $79,339
2018-06-30 $80,402
2018-03-31 $83,514
2017-12-31 $85,134
2017-09-30 $85,877
2017-06-30 $86,176
2017-03-31 $54,310
2016-12-31 $49,681
2016-09-30 $50,813
2016-06-30 $47,798
2016-03-31 $47,688
2015-12-31 $47,393
2015-09-30 $47,267
2015-06-30 $48,510
2015-03-31 $48,370
2014-12-31 $49,054
2014-09-30 $47,940
2014-06-30 $49,111
2014-03-31 $49,821
2013-12-31 $50,745
2013-09-30 $51,319
2013-06-30 $50,041
2013-03-31 $50,358
2012-12-31 $51,176
2012-09-30 $50,567
2012-06-30 $50,611
2012-03-31 $34,496
2011-12-31 $34,276
2011-09-30 $34,274
2011-06-30 $34,621
2011-03-31 $34,813
2010-12-31 $32,010
2010-09-30 $32,443
2010-06-30 $31,087
2010-03-31 $31,776
2009-12-31 $31,185
2009-09-30 $31,653
2009-06-30 $28,872
2009-03-31 $28,923
2008-12-31 $27,695
2008-09-30 $28,571
2008-06-30 $29,201
2008-03-31 $29,433
2007-12-31 $28,763
2007-09-30 $29,508
2007-06-30 $29,166
2007-03-31 $29,231
2006-12-31 $28,688
2006-09-30 $13,331
2006-06-30 $13,274
2006-03-31 $12,898
2005-12-31 $12,175
2005-09-30 $12,086
2005-06-30 $12,195
2005-03-31 $11,818
2004-12-31 $11,842
2004-09-30 $11,728
2004-06-30 $11,805
2004-03-31 $11,442
2003-12-31 $11,539
2003-09-30 $11,679
2003-06-30 $11,710
2003-03-31 $9,425
2002-12-31 $9,246
2002-09-30 $9,273
2002-06-30 $9,265
2002-03-31 $9,061
2001-12-31 $9,077
2001-09-30 $7,532
2001-06-30 $7,616
2001-03-31 $7,164
2000-12-31 $7,535
2000-09-30 $7,289
2000-06-30 $7,395
2000-03-31 $7,528
1999-12-31 $7,571
1999-09-30 $7,295
1999-06-30 $7,335
1999-03-31 $7,489
1998-12-31 $7,209
1998-09-30 $3,297
1998-06-30 $3,280
1998-03-31 $3,303
1997-12-31 $3,261
1997-09-30 $3,276
1997-06-30 $3,279
1997-03-31 $3,119
1996-12-31 $3,107
1996-09-30 $2,944
1996-06-30 $2,913
1996-03-31 $2,944
1995-12-31 $2,950
1995-09-30 $2,849
1995-06-30 $2,783
1995-03-31 $2,453
1994-12-31 $2,403
1994-09-30 $1,591
1994-06-30 $975
1994-03-31 $969
1993-12-31 $925
1993-09-30 $673
1993-06-30 $692
1993-03-31 $716
1992-12-31 $716
1992-09-30 $745
1992-06-30 $723
1992-03-31 $703
1991-12-31 $738
1991-09-30 $717
1991-06-30 $678
1991-03-31 $684
1990-12-31 $706
1990-09-30 $676
1990-06-30 $672
1990-03-31 $684
1989-12-31 $704
1989-09-30 $689
1989-06-30 $696
1989-03-31 $669
1988-12-31 $609
1988-09-30 $609
1988-06-30 $625
1988-03-31 $615
1987-12-31 $622
1987-09-30 $605
1987-06-30 $610
1987-03-31 $622
1986-12-31 $393
1985-12-31 $0
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $450.090B $94.943B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $495.141B 66.87
Novo Nordisk (NVO) Denmark $424.453B 49.78
Merck (MRK) United States $270.018B 37.87
AbbVie (ABBV) United States $264.086B 11.85
AstraZeneca (AZN) United Kingdom $218.471B 19.74
Novartis AG (NVS) Switzerland $218.425B 15.54
Pfizer (PFE) United States $201.199B 7.39
Sanofi (SNY) $132.955B 11.89
Innoviva (INVA) United States $0.953B 10.12